Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks
NCT ID: NCT00458770
Last Updated: 2014-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2009-05-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Circadian Changes of the Hypothalamic Activity in Patients Suffering From Cluster Headache
NCT04409977
Variability of the Autonomic Nervous System (ANS) During Cluster Headache (CH).
NCT04439409
Cluster Headache, Addictions and Vascular Function
NCT02640105
Actigraphy and Nocturnal Heartrate Variability in Cluster Headache Patients
NCT03010189
Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve Stimulation
NCT02081482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
position emission transaxial tomography
cerebral position emission transaxial tomography using 18Fluorodeoxyglucose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no serious illnesses in progress as cancer, autoimmune disease, liver disease
* patient without chronic psychiatric disease excluding moderate and reactional depression
* no demential disease
* no anxious or depressive disease
* no contraindication to PET scan (pregnancy and breast-feeding)
* social security cover
* written informed consent
Exclusion Criteria
* unable to realize a decubitus of 15 minutes long
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne DONNET, PH
Role: PRINCIPAL_INVESTIGATOR
Pôle de Neurosciences Cliniques CHU Timone, 204 rue St Pierre, Marseille 13385 cedex 5 France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pôle de Neurosciences Cliniques CHU Timone
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-A00149-48
Identifier Type: -
Identifier Source: secondary_id
2006/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.